Important Links:
Alison Krauss and Union Station

Gillian Welch
Willie Nelson
Iris DeMent
Emmylou Harris
C.F. Martin Guitar Company
Taylor Guitar Company
Gibson Mandolins
Slate
Edge
Children's Hospital Boston
Harvard Medical School
Harvard Stem Cell Institute
Fanconi Anemia Research Fund
Leukemia & Lymphoma Society
Charcot-Marie-Tooth Org
NAS
ISSCR
Friends of the Children
Nobel Museum
AAAS
ASH


My photo album

 
My Research:
     I want to know where blood comes from. Biologically, the blood (hematopoietic) system is fantastically intricate. The complexity of how it's regulated and responds to environmental stresses is on par with any other tissue or organ. All the parts of the body work together in a delicately balanced system of life. However, blood is among a select few parts of the body with additional, symbolic meaning. It is blood that is seen to carry our passions. It is blood that is used to identify our descendants (eg. our bloodline). It is blood that marks those among us with whom we enter into sacred kinship (eg. blood brothers). Literature contains abundant references to blood as a vehicle for understanding deeper human significance. As Sitwell said, "Blood is that fragile scarlet tree we carry with us." Works like Macbeth, The Blank Page (Karen von Blixen), and of course Dracula are just a few examples of how human kind sees blood as something more than cells and plasma pulsing through our vessels. Blood's symbolic nature alone is worthy of study.
     That said, blood is clearly more than poetically significant. People have studied the blood, both healthy and otherwise, for centuries. From Paracelsus' comments on splenomegally in the 1500's to the famous clotting disease of the Romanovs in Russia (and other royal households), what blood does, and how it does it, is of great scientific and medical interest. My background is in genetics and my particular research tries to understand what genes are involved in blood cell production, how that happens at the earliest stages when the first blood cell is made from its non-blood precursor, and how the entire process goes astray in disease. I do this work using human pluripotent stem cells of many types.
     The specific use of pluripotent stem cells is key to my work for at least two reasons: (1) I am interested in understanding the pathophysiology of human genetic diseases of the blood and (2) pluripotent stem cells are capable of making any type of cell in our bodies, but have yet to do it; they are a blank slate. Adult blood stem cells are eventually made in nature from a cell like a pluripotent stem cell and I want to understand how that works. The incredible developmental plasticity of pluripotent stem cells makes them perfect platforms for studying how one cell (the fertilized egg) is able to divide and make all of the hundreds of different types of cells in our bodies. This is the central question of developmental biology.
     Also, I have a growing interest in germ cell-related tumors including teratomas, teratocarcinomas, and similar masses as these naturally-occuring entities originate from pluripotent cells. Study of similar masses capable of generation in vitro using human pluripotent stem cells will no doubt improve our understanding of these tumors in vivo. Additionally, defining ways to best identify and eradicate tumor-forming cells will be an important milestone as regenerative medicine using materials engineered from human pluripotent stem cells advance towards clinical use.
The Ontogeny of Blood Production
For a large version of my Hematopoiesis figure, click here
If you'd prefer Haematopoiesis, click here instead
      Finally, the use of human pluripotent stem cells in research has renewed a centuries old debate into what it means to be human and also how far science should be allowed to go in order to combat human frailty. As such, the consideration of areas beyond, yet impacting science is of keen interest to me. Ethics, philosophy, scientific conduct, public policy, history, and education are important areas in which I work, publish, lecture, and discuss. No matter in what room I have found myself, whether among "friend" or "foe", I have been continually impressed by the desire of most folks to know more about science. What people lack for the most part is access, vocabulary, and examples and stories that make science real for them. While it is easily argued that the internet has eradicated the issue of access, I suggest that it has only compounded the situation for though there is certainly no lack of "information" on scientific topics, what is in short supply is GOOD information, authoritative commentary, and in language than makes science approachable and interesting to everyday people. I would further contend that public policy as it relates to science has also suffered from a low degree of "scientific literacy"; a comment that is capable of direction at lawmakers and members of the general public alike. As scientists we need to tell our stories better, to more people, and to fully appreciate the seriousness and consequences of failing to do so. Part of my work as a researcher is to bring science to the public, to tell stories, to highlight people throughout history, who they were, what they wanted to know, and how they went about things. I strive to do this in a manner that brings the work forward to the current day and to the sharpest part of the cutting edge. Spending time telling non-scientists about research is an investment in society and our future.
      If you are a scientist, I encourage you to schedule a public lecture at your local library. Tell people what you are doing, how long it has taken, and where you hope it will lead. Bring cookies, show slides, and answer questions. Never be afraid to say "I don't know". Take the time to tell people why you love science and who influenced your path. In other words, tell them your story. It won't be easy, but it will be worth it.
Things I've worked on over the years

Publications:
Click Here to Link to My Publications in PubMed at the National Library of Medicine

· Lensch MW. An evolving model of hematopoietic stem cell functional identity. Stem Cell Rev. 2012 Jun;8(2):551-60.
·
Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, Huo H, Loh YH, Aryee MJ, Lensch MW, Li H, Collins JJ, Feinberg AP, Daley GQ. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol. 2011 Nov 27;29(12):1117-9.

·
Lensch MW
. Public Perception of Stem Cell and Genomics Research. Genome Medicine. 2011 Jul 6;3(7):44.
·
Zhu H, Lensch MW, Cahan P, and Daley GQ. Investigating Monogenic and Complex Diseases with Pluripotent Stem Cells. Nat Rev Genet. 2011 Apr;12(4):266-75.
·
Lensch MW
and Ince T. Assaying Pluripotency via Teratoma Formation. in Human Stem Cell Technology and Biology: A Research Guide and Laboratory Manual, Gary Stein editor, Wiley, 2010. ISBN: 978-0-470-59545-9.
· Lensch MW. Science Education as Science Advocacy: A Personal View. World Stem Cell Report 2010, Genetics Policy Institute, pages 34-37. ISBN: 978-0-578-06809-1.
(go to article online, free registration required for full-text)
· Lensch MW and Rao M. Induced Pluripotent Stem Cells: Opportunities and Challenges. Regen Med. 2010 Jul;5(4):483-4.
· Loh Y-H, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Lensch MW, Park I-H, Agarwal S, Collins JJ, Irion S, and Daley GQ. Reprogramming of T cells from human peripheral blood. Cell Stem Cell, 2010 Jul 2;7(1):15-9.
· Tulpule A, Lensch MW, Austin K, D’Andrea A, Shimamura A, and Daley GQ. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood. 2010 Apr 29;115(17):3453-62. (cover article)

·
Lensch MW, Jaenisch R, Scadden DT, and Daley GQ. Konrad Hochedlinger: ISSCR Outstanding Young Investigator for 2009. Cell Stem Cell. 2009 Aug 7;5(2):154-5.
· Lensch MW. Cellular Reprogramming and Pluripotency Induction, Br Med Bull. 2009 90(1):19-35.
· Baek K-H, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park I-H, Yoon SS, Minami T, Reeves R, Korenberg JR, Folkman J, Daley GC, Aird WC, Galdzicki Z, and Ryeom S. Down syndrome: Protection against tumor growth and the role of the endogenous calcineurin inhibitor DSCR1 (Down syndrome candidate region-1). Nature, Jun 25;459(7250):1126-30.
· Adamo L, Naveiras O, McKinney-Freeman S, Mack PJ, Suchy-Dicey A, Yoshimoto M, Lensch MW, Yoder MC, García-Cardeña G, and Daley GQ. Biomechanical Induction of Hematopoiesis. Nature, 2009 Jun 25;459(7250):1131-5.

·
Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S. Broader implications of de
fining standards for the pluripotency of iPSCs, Cell Stem Cell. 2009 Mar 6;4(3):200-1.
·
Park I-H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, and Daley GQ. Disease-Specific Induced Pluripotent Stem Cells. Cell. 2008 Sep 5;134(5):877-86.
· Lensch MW and Sullivan S. The Cycle of Developmental Potency, (fold-out poster with glossary). 2008. Distributed in the journals Science and Differentiation by Abcam plc

·
Lensch MW. iPS Cells: The Needle of the Compass, BioWorld-Europe. 2008 Sept;2-3:14-16.
·
Park I-H, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, and Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008 Jan 10;451(7175):141-6.
· Lensch MW and West JA. Looking Into the Future of Cell-Based Therapy, South Med J. 2008 Jan;101(1):79-82.
· Lensch MW and Ince TA. The Terminology of Teratocarcinomas and Teratomas, Nat Biotechnol. 2007 Nov;25(11):1211-12.
· Agarwal S, Lensch MW, Daley GQ. Current prospects for the generation of patient-specific pluripotent cells from adult tissues. Regen Med. 2007 Sep;2(5):743-52.
· Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Teratoma Formation Assays with Human Embryonic Stem Cells: A Rationale for One Type of Human-Animal Chimera. Cell Stem Cell. 2007 September, 2007: 1 (3):253-8.
· Wu X*, Lensch MW*, Wylie-Sears J, Daley GQ, Bischoff J. Hemogenic Endothelial Progenitors Cells Isolated from Human Umbilical Cord Blood. Stem Cells. 2007, 25:2770-6 (*co-first authors).
· Lensch MW and Daley, GQ. Embryonic Stem Cells Flock Together (News and Views), Nat Biotechnol. 2007 Jul;25(7):748-750.
· Lensch MW, Tulpule A, and Zaehres, H. RNA Interference in Human Embryonic Stem Cells. Human Embryonic Stem Cells: A Practical Handbook, John Wiley & Sons, Ltd., Sullivan, Eggan, and Cowan, eds. (2007).
· Schlaeger TS, Lensch MW, and Taylor PL. Science Aside: The Trajectory of Embryonic Stem Cell Research in the USA. Drug Discov Today. 2007 Apr;12(7-8):269-71.
· Lensch MW, Daheron L, and Schlaeger TS. The Pluripotent Stem Cell Niche. Stem Cell Rev. 2006;2(3):185-202.
· Lensch MW and Daley GQ. Scientific and Clinical Opportunities for Modeling Blood Disorders with Embryonic Stem Cells. Blood. 2006 Apr 1;107(7):2605-12.
· Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J, Daley GQ. High-efficiency RNA interference in human embryonic stem cells. Stem Cells. 2005, 23(3):299-305.
· Dahéron L, Opitz SL, Zaehres H, Lensch MW, Andrews PW, Itskovitz-Eldor J, Daley GQ. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells. 2004, 22(5):770-8.
· Lensch MW and Daley GQ. Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models. Gerald Shatten ed. Curr Top Dev Biol. 2004;60:127-96.
· Lensch MW, Tischkowitz M, Christianson TA, Reifsteck C, Speckhart SA, O'Dwyer ME, Jakobs P, Olson SB, LeBeau MM, Mathew CG, Hodgson SV, Larson R, Bagby GC. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia (Plenary Paper). Blood. 2003 Jul 1;102(1):7-16.
· Lensch MW. Clonal Selection: The Leukemic Process in Fanconi Anemia, Graduate Thesis, March 15, 2002, Oregon Health & Science University, Portland, Oregon.
· Fagerlie S, Lensch MW, Pang Q, Bagby GC. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells. Exp Hematol 2001 Dec;29(12):1371-81.
· Lensch MW, Rathbun RK, Olson SB, Jones GR, Bagby GC Jr. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: A view from the Fanconi anemia window. Leukemia 1999 Nov;13(11):1784-9.
· Pellegrino JE, Lensch MW, Muenke M, Chance PF. Clinical and molecular analysis in Joubert syndrome. Am J Med Genet. 1997 Oct 3;72(1):59-62.
· Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer. 1996 Apr 1;77(7):1356-62.
· Kiyosawa H, Lensch MW, Chance PF. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP. Hum Mol Genet. 1995 Dec;4(12):2327-34.
· Bone LJ, Dahl N, Lensch MW, Chance PF, Kelly T, Le Guern E, Magi S, Parry G, Shapiro H, Wang S, Fischbeck KH. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology. 1995 Oct;45(10):1863-6.
· Chance PF, Lensch MW, Lipe H, Brown RH Sr, Brown RH Jr, Bird TD. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct genetic disorders. Neurology. 1994 Dec;44(12):2253-7.
· Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet. 1994 Feb;3(2):223-8.
· Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993 Dec 24;262(5142):2039-42.
· Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 1993 Jan 15;72(1):143-51.
· Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurology. 1992 Dec;42(12):2295-9.
· Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, Hanemann CO, Muller HW, Bird TD, White R, Chance PF. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet. 1992 Jun;1(3):176-9.
· Chance PF, Matsunami N, Lensch W, Smith B, Bird TD. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type 1 pedigrees: additional evidence for a third autosomal CMT1 locus. Neurology. 1992 Oct;42(10):2037-41.

Teaching:
· 2011 - present -  Faculty Director of Education, Harvard Stem Cell Institute, Harvard University, Cambridge, MA. Responsible for advising on programmatic aspects of educational outreach for the HSCI including public lectures, Teachers' Week, the 10 week Undergraduate Internship (Program Director), and end of summer Internship Research Symposium.
· 2011 -  Knop Visiting Scholar, Ripon College, Ripon, WI. Guest lectures in Organic Chemistry, Biochemistry, Molecular Biology, Developmental Biology, Professional Ethics,and Comparative Religious Ethics.
·
2010 -  Guest Lecturer, Developmental Biology (Biol 302), Smith College, Northampton, MA.

· 2010 -  Guest Lecturer, Biomaterials, Tissue Engineering, and Regenerative Therapeutics (HST 521), Harvard Medical School/Massachusetts Institute of Technology, Boston, MA.
· 2010 -  Guest Lecturer, University Seminar: Stem Cells and Human Enhancement – Scientific Frontiers, Ethics, and Policy, Tufts University, Medford, MA.
· 2010 -  Guest Lecturer, Biotechnology Study Class, Industrial College of the Armed Forces visit to Harvard Medical School, Boston, MA.
· 2010 -  Guest Lecturer, Stem Cell Biology (PNB 3260), University of Connecticut, Storrs, CT.
· 2009 -  Guest Lecturer, Science, Technology, Innovation, and Public Policy (IGA 205), Kennedy School of Government, Harvard University, Cambridge, MA.
·
2009 - Guest Lecturer, SHH234. Life Sciences & Public Health: Contemporary Issues & Challenges, Harvard School of Public Health, Boston, MA. Course Director, Robin J.R. Blatt.
· 2008 - 2011 -  Faculty Advisor for Education, Harvard Stem Cell Institute, Harvard University, Cambridge, MA. Faculty member responsible for advising on programmatic aspects of educational outreach for the HSCI including public lectures, Teachers' Week, the 10 week Undergraduate Internship (Program Director), and end of summer Internship Research Symposium.
· 2008 - present -  Course Organizer and Head Teaching Assistant, SCRB 167: Stem Cells in Disease: Pathobiology and Treatment, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA. Course Director, George Q. Daley. Final evaluation 4.9/5.0 (Superior - Recipient of Harvard University Certificate of Distinction in Teaching from the Derek Bok Center for Teaching and Learning, Harvard University in 2009 and 2010).
· 2008 - present -  Course Co-Director and Lecturer, Ethical and Policy Issues at the Cutting Edge of Stem Cell Science: A Summer Intensive Course, The Harvard Stem Cell Institute and the Department of Bioethics at Case Western Reserve University, Harvard University, Cambridge, MA.
· 2008 - present -  Course Director and Instructor, Harvard Stem Cell Institute's Teachers' Week, Cambridge, MA, Week-long intensive course on stem cell history, ethics, policy, therapeutics, and science for public and private school educators. Includes eight stem cell-specific lectures, laboratory visits, and panel discussions.
· 2008 -  Guest Lecturer, Courses in Biology and Honors Biology, The Rivers School, Weston, MA, Kimberly Johnson Kopelman, course director.
· 2008 -  Guest Lecturer, Course: Biology 5230, Developmental Biology, Utah State University, Gregory Podgorski, course director.
· 2007- present -  Course Director and Instructor, 10-week Harvard Stem Cell Institute Summer Interns Program (HIP) Companion Course on Stem Cells (non-credit) and HSCI Internship Program Summer Faculty Seminar Series. Course provides foundation for undergraduates participating in intensive, independent summer research projects. Sessions devoted to terminology/technology, ethics/policy, history of stem cell research, and journal club to develop critical thinking and interpretation of current literature. ~36 to 47 domestic and international students annually. Harvard Stem Cell Institute, Harvard University.
· 2007 -  Guest Lecturer, Capstone Seminar in Biological Chemistry (BIOC 340), "Stem Cells: A Long Road of Scientific Advance, a Short Road of Political Turmoil". Wellesley College, Mary Allen, Ph.D., course director.
· 2007 -  Guest Lecturer, Master's Program, The Center for Science and Medical Journalism, College of Communication, Boston University, Doug Starr, course director.
· 2006 -  Guest Lecturer, Course: Science News Writing (21W.728), Massachusetts Institute of Technology, B.D. Colen, course director.
· 2006 -  Guest Faculty, "Introduction to the Science of Stem Cells", Suffolk University Law School, Annual Intellectual Property Law Conference, Boston, Massachusetts.
· 2005 -  Guest Lecturer, Course: Journalism for the Future, Writing about Science. Tufts University, Cynthia Gruber, course director.
· 2004 - present -  Founding Co-Director, Brown Bag Bioethics Discussion, Division of Hematology/Oncology, Children's Hospital Boston and the Harvard Stem Cell Institute. Louis Guenin, moderator.
· 2002 - present -  Student Project Mentor, Whitehead Institute (MIT, 2002 - 2004) and Children's Hospital Boston (2004 - present). Supervision and training of various high school, undergraduate, and graduate/medical students in research projects ranging in duration from one week to a few months.
· 1999 - 2000 -  Lecturer and Course Co-Designer, Essentials of Molecular and Medical Genetics (MGEN 610), School of Medicine, Oregon Health Sciences University. Led three sections in graduate genetics refresher for incoming students: Population genetics, cancer genetics, ethics/privacy, and gene mapping. Susan B. Olson, Ph.D. course director. Participated in the design and implementation of this survey course in order to provide teaching experience for graduate students.

Patents:
· Chance PF, Alderson MK, Odelberg SJ, and Lensch MW. Deletion in chromosome 17p11.2-12 which causes the disorder hereditary neuropathy with liability to pressure palsies. United States Patent number 5,645,993 issued July 8, 1997. (go to patent)

Public Policy Commentaries:
·
2010 Invited speaker, "Stem Cell Research: Developments in Light of Recent Court Activity", Boston Bar Association, Life Sciences Committee and Health Law Section, Boston, Massachusetts.
· 2010 Invited Testimony/Policy Commentary, "Pluripotent Stem Cell Chimeras and State Funding", Empire State Stem Cell Board, Ethics Committee, New York, New York.
· 2010 Policy Commentary/Recommendation, "Comments on a Proposed Change to the Definition of ‘Human Embryonic Stem Cells’ in the NIH Guidelines for Human Stem Cell Research", National Institutes of Health, Bethesda, Maryland.
· 2010 Invited speaker, Spinal Cord Injury Awareness Day, Massachusetts State House, Boston, Massachusetts. Eric Ruby, M.D. Massachusetts Walks, organizer.

·
2009 Invited testimony/Policy Commentary, "Stem Cell Hybrids and Chimeras: History and Scientific Utility", Empire State Stem Cell Board, Ethics Committee, New York, New York.
·
2009 Policy Commentary/Recommendation, "Comments on Draft NIH Human Stem Cell Guidelines", National Institutes of Health, Bethesda, Maryland.
·
2007 Briefing, "Recent advances in stem cell research; implications for Massachusetts policymakers", Governor's Office, Commonwealth of Massachusetts.
·
2007 Testimony, "Testimony Regarding the Advancement of the Life Sciences in the Commonwealth of Massachusetts", SB.4234, Commonwealth of Massachusetts State House, Joint Committee on Economic Development and Emerging Technologies.
· 2007 Invited speaker, Spinal Cord Injury Awareness Day, Massachusetts State House, Boston, Massachusetts. Eric Ruby, M.D., organizer.
· 2007 Co-author, Report to the Office of the Governor and the General Assembly, Stem Cell Research Advisory Committee, Connecticut Department of Public Health, regarding Public Act 05-149, An Act Permitting Stem Cell Research and Banning the Cloning of Human Beings.
· 2007 Panelist, Interstate Collaboration on Stem Cell Research, Legislative Office Building, Hartford, Connecticut. StemCONN 07.
· 2007 Invited speaker, Media and Legislative Briefing, Old Judiciary Room, The Capitol, Hartford, Connecticut. StemCONN 07.
· 2007 Co-author, Report to the Office of the Governor and the General Assembly, Umbilical Cord Blood Ad Hoc Committee, Connecticut Department of Public Health, regarding Public Act 06-77, An Act Concerning the Establishment of a Public Umbilical Cord Blood Bank.
· 2006 Testimony, "Comments on Science and Policy in Stem Cell Research", Congressional Simulation for students, Kennedy School of Government, Harvard University.
· 2005 Lecture and Panel, Town Hall Meeting on Stem Cell Research, Jamaica Plain, Massachusetts. State Representative Jeffrey Sanchez, moderator.
· 2005 Lecture and Panel, "Being a Young Investigator in a Contentious Field" at "The Politics and Promise of Stem Cell Research", Howard Hughes Medical Institute (HHMI) in collaboration with the Center for Strategic and International Studies (CSIS), Washington, D.C., Leonard Zon, organizer.
· 2004 Research Advocacy/Lobbying, Joint Steering Committee for Public Policy (ASCB), Capitol Hill Day, Washington, D.C.
· 2004 Lecture, "Stem Cell Research: Origins, State of the Art, and Future Directions", MIT Senior Congressional Staff Seminar: "Social and Policy Implications of Advancing Health Science and Technology", Stephen Ansolabehere, Ph.D. and Robert Weinberg, Ph.D., organizers. Jonathan Gruber, Ph.D., moderator.
· 2003 Testimony, "Stem Cell Research", State of Utah Legislature, Democrat Representatives' Caucus.
· 2003 Testimony, "Stem Cell Research", Commonwealth of Massachusetts State House, joint legislative session on stem cell research.

Lectures/Articles/Other Media Relating to Science:

2011
· Invited speaker, "Science in the Public Square: Is Regenerative Medicine Real?, Knop Scholar Public Lecture, Ripon College, Ripon, Wisconsin
· Invited speaker, "Pluripotent Stem Cells as Tools for Discovery in Human Genetic Disease", Departments of Chemistry and Biology, Ripon College, Ripon Wisconsin
· Invited speaker, "Modeling of Shwachman-Diamond Syndrome Using Pluripotent Stem Cells", NHLBI Progenitor Cell Biology Consortium, Steering Committee Meeting, Bethesda, Maryland.
· Invited speaker, "Disease-Specific Induced Pluripotent Cells", American Association of Anatomists Annual Meeting, Experimental Biology (FASEB) 2011, Washington, D.C.
· Invited speaker, “Modeling SDS in vitro Using Human Pluripotent Stem Cells”, Sixth International Congress on Shwachman-Diamond Syndrome, The New York Academy of Sciences, New York, New York.
· Invited speaker, Leadership in Math and Science Careers - Pioneer Charter School of Science, Everett, Massachusetts.
Interview, "Labcations", The Scientist, Vanessa Schipani, author. v.25,n.1, Jan. 2011
· Invited speaker, "Blood Stem Cell Biology and Therapies", Taking Stock of Stem Cells, Whitehead Spring Lecture Series for High School Students, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
· Invited speaker, "Do We Still Need Embryonic Stem Cells or Has the Research Passed Them By?", Keynote Address, The Stem Cell Odyssey Continues, Nixon Peabody LLP, Boston, Massachusetts.
· Invited speaker, “Stem Cells: Science and Ethical Considerations”, Summer Research Program, Wellesley College, Wellesley, Massachusetts.

2010
· Invited speaker, "Les iPS: une nouvelle source de cellules souches pluripotentes", Congrès de la Société Française d’Hématologie, Paris, France.
· Invited speaker, "Induced Pluripotent Stem Cells", Stem Cell Models for Environmental Health, Emerging Science for Environmental Health Decisions, Keck Center, The National Academy of Sciences, Washington, D.C.
· Invited speaker, "Cellular Reprogramming: Basics, Disease-Specific Cells, and Epigenetic Memory", World Stem Cell Summit, Detroit, Michigan.
· Invited speaker, "Human Disease-Specific iPSC", NHLBI Progenitor Cell Biology Consortium, Annual Investigators' Meeting, Fred Hutchinson Cancer Research Center, Seattle, Washington.
· Invited speaker, "Human Marrow Failure and iPSC", Keynote Address, 22nd Annual Fanconi Anemia Research Fund Scientific Symposium, Minneapolis, Minnesota.
· Invited speaker, "U.S. Regenerative Medicine Landscape", US-UK Workshop on Regenerative Medicine, British Consulate-General, Cambridge, Massachusetts.
· Invited speaker, "Modeling Congenital Bone Marrow Failure with Human Pluripotent Stem Cells", Life Sciences Colloquium Lecture Series, Smith College, Northampton, Massachusetts.
· Invited speaker, "Stem Cells and the Future of Hematological Disease Therapy", Massachusetts Association of Blood Banks Annual Meeting, Westford, Massachusetts.
· Invited speaker, "A Review of Recent Advances in the Science of Stem Cells", Keynote Address, 2010: A Stem Cell Odyssey, Nixon Peabody, LLP. Boston, Massachusetts.
· Invited speaker, "Human Stem Cell Research", Signature Healthcare Brockton Hospital Annual Dinner and CME lecture, Brockton, Massachusetts.
· Invited speaker, Afternoon Conversations with Stem Cell Experts, World Stem Cell Summit Public Stem Cell Education Day, Detroit Science Center, Detroit, Michigan.
· Invited speaker, Stem Cell Advocacy Panel, World Stem Cell Summit Public Stem Cell Education Day, Detroit Science Center, Detroit, Michigan.
· Interview, “Finally, a Use for Wisdom Teeth”, Everyday Health.com, Karen Weintraub, Everyday Health Contributing Editor, author.
· Interview, “Getting It Right on Stem Cells”, Scientific American, Jeneen Interlandi, Just the Facts, author. November 2010 Issue.
· Interview, “Putting Stem Cells to the Test”, Nature Medicine, Elie Dolgin, author. v.16, no.12, Dec. 2010.

2009
· Invited speaker, "Pluripotent Stem Cells and Human Disease Modeling: A Scientific Revolution", Department of Genetics and Center for Stem Cell & Regenerative Medicine, Case Western Reserve University, Cleveland, Ohio.
· Invited speaker, "Ethics, Science, and Policy: A Scientist's Perspective", Department of Bioethics, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
· Invited speaker, "Modeling Marrow Failure with Human Pluripotent Stem Cells", Keynote Address, 21st Annual Fanconi Anemia Research Fund Scientific Symposium, Baltimore, Maryland.
· Invited speaker, "Stem Cell Basics", Hot Issues in Medicine, Massachusetts College of Pharmacy and Health Sciences, Boston, Massachusetts.
· Invited speaker, "Stem Cells in Surgery", 56th Annual Meeting, Massachusetts Chapter of the American College of Surgeons, Boston, Massachusetts.
· Invited speaker, "Stem Cells and the Future of Cancer Therapeutics", Keynote Address: Carolyn Jaffe Memorial Lecture, Advances in Cancer Research and Practice, Presented by Columbia University Medical Center & The Herbert Irving Comprehensive Cancer Center and New York-Presbyterian Hospital, New York, New York.
· Interview, "Need a New Heart? Grow Your Own.", Boston Globe Sunday Magazine, Cynthia Graber, author.
· Commentary, "A Good Day for Stem Cell Research", Thrive, Children's Hospital Boston.
· Interview, “13 new stem cell lines get NIH approval”, American Medical News, Doug Trapp, author.
· Interview, "Biotech Lawyer Rolls up Sleeves for Stem Cell Harvest", Boston Business Journal, Lisa van der Pool, author.
· Invited speaker and panelist (with Alta Charo, J.D.) "Human Pluripotent Cell Research: New Science and New Guidelines" in NIH Stem Cell Guidelines: Scientific, Ethics, and Policy Perspectives during Smart ART X: From Physiology to Clinical Success, Orlando, Florida.
· "Modeling Congenital Blood Disease with Human Embryonic Stem Cells", Division of Hematology/Oncology Floor Meeting, Children's Hospital Boston, Boston, Massachusetts.
· "Points of Consideration in the Ethics of Stem Cell Research", Brandeis University Genesis Program, Innovation and Revolution: The Relationship between Technology and Science, Harvard Stem Cell Institute, Cambridge, Massachusetts.
· Invited speaker, "Stem Cell Research and Policy: A Short Introduction", Genuine Interactive, Boston, Massachusetts.
· Interview, "NIH Loosens Stem Cell Consent Rules", The Scientist, Elie Dolgin, author.
· Essay, "New Stem Cell Guidelines Released Today", Thrive: Children's Hospital Boston's Health and Science Blog.
· Interview, "Success with iPSCs", The Scientist, Vol. 23, Issue 7, page 59, Elie Dolgin, author.
· "Stem Cell Research and Policy: What a Long, Strange Trip It's Been", Harvard Stem Cell Institute Summer Seminar Series for Undergraduates, Harvard University, Cambridge, Massachusetts.
· "Human/Animal Chimeras and Hybrids - History and Scientific Utility", Ethical and Policy Issues at the Cutting Edge of Stem Cell Science: A Summer Intensive Course, Case Western Reserve University and Harvard Stem Cell Institute, Cambridge, Massachusetts.
· Invited speaker, "Stem Cell Biology, Philosophy, and Policy: The Road Ahead", Whitehead Seminar Series for High School Teachers: Pursuing the Promise: Advances in Stem Cell Science, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
· Interview, "Patched-up Human Stem Cells", The Scientist, Elie Dolgin, author.
· Invited speaker, "The State of Stem Cells", Harvard Business School, Class of 1959, 50th Reunion Program, Harvard University, Allston, Massachusetts.
· Interview, "Controversy doesn't derail stem cell progress", USA Today, Dan Vergano, reporter.
· Panel Discussion, "Hope Deferred", Screening of a stem cell documentary, Kennedy School of Government, Harvard University, Cambridge, Massachusetts.
· "Blood Stem Cells: Current and Emerging Technologies", OCS Spring Molecular Biology Seminar: Stem Cell Biology & Regenerative Medicine, MITRE Corporation, McLean, Virginia.
· Live Radio Interview and Guest DJ Slot, "Stem Cell Research and Policy", Soundtrack Science, WMBR FM (MIT), Cambridge, Massachusetts, Annie Glausser, host.
· Interview, "Children's stem cell researchers are rewinding cellular time to open a vast frontier of future treatments", Vector, Spring 2009, Laurie Beckelman, author.
· "Stem Cells in the Future of Medicine", Fox Hill Village Retirement Center, Westwood, Massachusetts.
· Interview, "Obama Executive Order: For Congress and NIH, Headaches Ahead on Stem Cells", Science, Constance Holden, author.
· "Modeling Congenital Marrow Diseases Using Human Pluripotent Stem Cells", Tenth Annual Diamond Blackfan Anemia International Consensus Conference, New York City, New York.
· Interview, "Levée des restrictions sur les cellules souches embryonnaires: Un grand soulagement", 20 Minutes France, Philippe Berry, author.
· "Development, Cellular Reprogramming, and Stem Cells: A 350 Year Perspective", Grinnell College, Grinnell, Iowa.
·  "Stem Cells in 2009: Ethics and Policy", Grinnell College, Grinnell, Iowa.
· "Pluripotency and Cellular Reprogramming", Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, Iowa.
· Interview, "Piggybacking to Pluripotency", The Scientist, Elie Dolgin, author.
· "Stem Cells in a New Political Era: Obama and Beyond", Stem Cell Research Seminar, Center for Bioethics, Brigham and Women’s Hospital, Boston, Massachusetts.
· Stem cells, Children's Hospital Boston Legislative Breakfast Briefing, State House at Beacon Hill, Massachusetts State Legislature, Boston, Massachusetts.
· Panel Discussion, "The Accidental Advocate", Screening of a stem cell documentary, Harvard Stem Cell Institute and the Kendall Square Cinema, Cambridge, Massachusetts.

2008
· Keynote speaker, "Obama's victory and stem cell research: A new era?", Nixon Peabody LLP, Boston, Massachusetts.
· "Stem Cells on Background ", Nieman Foundation for Journalism, Harvard University, Cambridge, Massachusetts.
· Invited speaker, "Stem Cells in 2008", Vital Social Issues Course, Lifelong Learning, Regis College, Weston, Massachusetts, Jill Rosen, course director.
· Lecture and Panel Discussion, "Stem Cells: Science, Ethics, and Policy", Cushing Academy, Ashburnham, Massachusetts.
· Panel Discussion, "Stem Cells: Where Do We Go From Here?", The Northern New England Region of Hadassah and the Merrimack Valley Chapter, Memorial Hall Library, Andover, Massachusetts.
· Panel Discussion, "Stem Cells in the Classroom", The 2008-2009 Whitehead Seminar Series for High School Teachers: Pursuing the Promise: Advances in Stem Cell Science, Boston Stem Cell Science Education Symposium, Whitehead Institute for Biomedical Research and Broad Institute, Cambridge, Massachusetts.
· Panel Discussion, "The State of Stem Cell Research: Its Promise, Its Politics, and Science", The Southern New England Chapter of Hadassah, Needham Public Library, Needham, Massachusetts.
· Invited speaker, "Pluripotency and the Forth Rail Bridge", Harvard Institute for Learning in Retirement (HILR), Harvard Extension School, Course on Stem Cells, Dr. Irving Bailit, course director.
· Lecture, "Animal-Based Studies in the Daley Laboratory", ARCH All-Staff Meeting, Children's Hospital Boston, Boston, Massachusetts.
· Interview, "Brasil desenvolve sua 1º linhagem de célula-tronco embrionária", de O Estado de S. Paulo, São Paulo, Brazil, Herton Escobar, author. http://www.estadao.com.br/vidae/not_vid250966,0.htm
· Interview, "Spory o elixír", Casopis Respekt - Téma (Czech Republic) 41/2008, Martin Uhlír, author.
· Essay, "Mixing Pipettes and Politics", Stem Cell Lines, The Newsletter of the Harvard Stem Cell Institute. Summer, 2008, Cambridge, Massachusetts.
· Interview, "Hairy Tumors and the Rare 17th Century Text", Utah State Magazine, Vol. 14, no. 2, Summer, 2008, Utah State University, Logan, Utah.
· Interview, "Growing blood in a dish; using stem cells to screen for breast cancer", Elie Dolgin, author, The Niche: The Stem Cell Blog, Nature Reports Stem Cells.
· "Seventeen Centuries of 'Science' and Some Other Stuff", Harvard Stem Cell Institute Summer Seminar Series for Undergraduates, Harvard University, Cambridge, Massachusetts.
· Invited speaker, "Current legislative efforts to prohibit human/animal hybrids and chimeras", HSCRR Meeting, Children's Hospital Boston, Boston, Massachusetts.
· Lecture and Panel Discussion, "Seeing the Whole Elephant in Stem Cell Research", The Greater Boroughs Chapter of Hadassah, B'nai Shalom Social Action and Adult Education Committees, Westborough, Massachusetts.
· Lecture and Discussion, "Exploring the Concept of Dignity: Stem Cell Research and the 'Natural' World", Brown Bag Bioethics Discussion, Division of Hematology/Oncology, Children's Hospital Boston and Harvard Stem Cell Institute.
· Invited speaker, "Stem cells in medical application and in ethical debate", Northeast Region Medical Laboratory Conference Convention Exhibition (NERCE) trade show, Boxborough, Massachusetts.
· "The Cycle of Pluripotency", Keynote Address, United Kingdom National Stem Cell Network (UKNSCN) Inaugural Scientific Meeting, Heriot-Watt University, Edinburgh, Scotland, UK.
· Interview, "Stem Cell 'Cure' for Stroke Victims", Daily Record (United Kingdom), Natalie Walker, reporter.
· News Interview, "Scientists Defend Stem Cell Research", STV (Edinburgh, Scotland), David Cowan, reporter.
· "Obtaining Development Insights via Pluripotent Cells", Wolfson Centre for Stem cells, Tissue Engineering and Modelling (STEM), University of Nottingham Centre for Biomolecular Sciences University of Nottingham, UK.
· Interview, "Stem Cell Research May Not Find Wonder Cures", The Scotsman (United Kingdom), Lindsay Moss, reporter.
· "Stem Cells as Platforms for Discovery in Development and Disease", Department of Biology, Utah State University, Logan, Utah.
· "Stem Cells, Cloning, and Regenerative Medicine: A 1,700 Year Perspective", Department of Biology, Utah State University, Logan, Utah.
· "Medical Science in Mid-17th Century Europe: A Contextual Analysis of Sculteto's 1658 Work on Teratomas", Department of History, Program in Classics, Utah State University, Logan, Utah.
· Invited speaker, "Stem Cell Research at Children's Hospital", Children's Hospital Boston Trust, Boston, Massachusetts.
· Invited speaker, "Regulating Stem Cell Research", Boston Bar Association, Life Sciences Committee and Health Law Section, Boston, Massachusetts.
· Magazine Interview, "Stem Cell Might One Day Revive an Athlete's Career", Sports Illustrated, Caitlin Moscatello, author.
· Essay, "Breakthroughs in stem cell biology: Human iPS cells", International Society for Stem Cell Research, public education website. http://www.isscr.org/public/briefings/breakthrough.html
· Magazine Interview, "Customized Stem Cells: Reprogramming cells taken from disease sufferers could lead to new treatments", MIT Technology Review, March/April 2008, Emily Singer, author.
· "The Pluripotent Cell Niche", Timberline Symposium, Oregon, Program Co-chairs Petra Boukamp, Ph.D. and Jonathan Garlick, D.D.S., Ph.D.
· Invited speaker, "Stem Cells: A Cornucopia of Issues", Children's Hospital Boston Trust, Communications, and Public Affairs Roundtable Luncheon, Boston, Massachusetts.
· Magazine Interview, "Next Steps for Stem Cells: New methods to reprogram adult cells could create novel models of disease", MIT Technology Review, Emily Singer, author.

2007
· Live Radio Interview, "Stem cells from skin", Leslie Marshal for Michael Jackson (KGIL), Los Angeles, CA.
· Live Radio Interview, "New sources of stem cells from skin", Leslie Marshall (Nationally Syndicated), Buffalo, New York.
·  Interview and Public Question/Answer, "Readers' Questions: Stem Cells" to accompany, "New Stem Cell Method Could Ease Ethical Concerns", New York Times, Gina Kolata, reporter.
·  Interview, "Stem cell discovery discussed", BBC Worldwide News, London, UK., Matt Frei, Reporter.
· Interview, "Stem cells model disease - Embryonic stem cell study uncovers mechanism for Fragile X gene mutation", The Scientist, Steve Mitchell, author.
·  Commentary, "Can Massachusetts Win the Life Sciences World Series?", Xconomy.com. http://www.xconomy.com/2007/11/12/can-massachusetts-win-the-life-sciences-world-series/
· Interview, "What a long strange trip it's been", Alumni Spotlight (Utah State University), Aggie Insights, vol. 5, #11, November 2007. Logan, Utah.
· "Stem Cells: A Cornucopia of Issues", Nieman Foundation for Journalism, Harvard University, Cambridge, Massachusetts.
·  Interview, "A Man of Science, and Conscience", Hypercube: Science in All Dimensions, Boston University, Jenna Beck, author.
· Invited speaker, "Stem Cell History, Politics, and Science", Harvard Institute for Learning in Retirement (HILR), Harvard Extension School, Course on Stem Cells, Dr. Irving Bailit, course director.
· "Obtaining Blood Products from Primitive Sources", Invited Faculty Presentation, at Molecular Mechanisms in Stem Cell Therapy, AABB Annual Meeting, Anaheim, California.
· "Embryonic Stem Cells: History, Current Concepts, and Goals", Beth Israel Deaconess Medical Center, Boston, Massachusetts.
· "Stem Cell Therapy: Where Are We and Where Are We Going", Combined Pathology Grand Rounds, Brigham and Women's Hospital, Boston, Massachusetts.
· Invited speaker, "A Little History and Some Big Questions", Bioethics Brown Bag Discussion, Massachusetts General Hospital. Laurence Daheron, Ph.D. organizer.
· Invited speaker, Spinal Cord Injury Awareness Day, Massachusetts State House, Boston, Massachusetts. Eric Ruby, M.D., organizer.
· Magazine Interview, "Crossing the Lines", Discover Magazine, October 2007, Stephen S. Hall, author.
· "Stem Cells in Research and Clinical Practice", Grand Rounds, Exeter Hospital, Exeter, New Hampshire.
· Commentary, "The New Valley of Death", Nature Network Boston.
· Commentary, "The Deval Is In the Details", Xconomy.com.
· "Stem Cells at the Confluence of Science and Ethics", Wellesley College, Wellesley, Massachusetts.
· Speaker and Panelist, Film screening, "Mapping Stem Cell Research: Terra Incognita", Independent Lens (PBS), Boston Cares, Sarah Lally, Citizen Academy Program Coordinator and event organizer, Boston, Massachusetts.
· Speaker and Panelist, "Law, Business, and Policy in Stem Cell Research", Professional Development Course for Teachers: Stem Cell Science and Technology, Harvard Stem Cell Institute, Cambridge, Massachusetts.
· Invited speaker, "Development: It's Not Just for Frogs Anymore", Grey Thumb Boston, The Boston Metro Area Technobiology Interest Group, Cambridge, Massachusetts.
· "The Long and the Short of Stem Cells", Harvard Stem Cell Institute Summer Seminar Series, Harvard University, Cambridge, Massachusetts.
· Commentary, "Deval Patrick Needs You", Xconomy.com.
· Radio Interview, "Bush Vetoes Stem Cell Research", Free Speech Radio News (Pacifica Radio), Leigh Ann Caldwell, reporter.
· Commentary, "The Curious Origins of the Term 'Stammzelle'", Cell Stem Cell.
· "The Analysis of Complex Genetic Syndromes Using Disease-Specific Human Embryonic Stem Cell Lines", Harvard Stem Cell Institute Annual Retreat, Cambridge, Massachusetts.
·  Invited speaker, "The Science of Stem Cells", at Stem Cells 2010: What Lies Ahead. Nixon Peabody LLP, Boston, Massachusetts.
· Invited speaker, "The Promise of Stem Cells: An Educational Evening on Stem Cell Research", Greater Boroughs Chapter of Hadassah and the Westborough Area Jewish Community Center, Westborough, Massachusetts.
·  Speaker and Panelist, "10 Unanswered Questions in Stem Cell Research", Cambridge Science Festival, Radcliffe College, Cambridge, Massachusetts.
· "The Ethics, Policy, and Law of Stem Cell Research", Speaker and panelist, Columbia Law School, Columbia University, New York, New York.
· Panelist, Interstate Collaboration on Stem Cell Research, Legislative Office Building, Hartford, Connecticut. StemCONN 07.
· Invited speaker, Media and Legislative Briefing, Old Judiciary Room, The Capitol, Hartford, Connecticut. StemCONN 07.
· "Stem Cell Research: More than Science", Invited Speaker. 12th Annual Symposium on Biotechnology Education. Museum of Science, Boston, Massachusetts.
· "Stem Cell Public Forum: Religious Perspectives on Stem Cell Research", Panelist, Harvard Stem Cell Institute and Harvard Divinity School. Philip Clayton, Ph.D., Moderator.
· "‘Recycling’ life: UMass Memorial revives cord blood program for stem cell transplants", Newspaper interview, Telegram & Gazette, Worcester, MA. Elizabeth Cooney, author.
· "Stem Cell Bill Passes House; Veto Looms", News interview, CBS-4 News, Boston.
· "Less Controversial Way to Harvest Stem Cells", Live News Interview/Call-In, ABC News Video, Be Seen, Be Heard. New York.
· "Scientists Extract Stem Cells from Amniotic Fluid", News interview, New England Cable News (NECN), Boston.
· "Report Shows Amniotic Fluid Yields Stem Cells", News interview, CBS-4 News, Boston.
· "ES Cells in the Study of Development" at "Therapeutic Potential of Stem Cell Research: from Test Tube to Bedside", University of Newcastle, Newcastle upon Tyne, UK.

2006
· Stem Cell Public Forum, Moderated Book Discussion with Authors Eve Harold, Christopher Thomas Scott, and Michael Bellomo, Harvard Stem Cell Institute and Radcliffe Institute for Advanced Study. M. William Lensch, Moderator.
·  "The Science of Stem Cells", Southern Medical Association Centennial Meeting, Charlotte, North Carolina.
· "New Hope for Stem Cells, or Just More Hype?", Invited Commentary, PharmaDD Magazine.
· "Stem cell experiment killed embryos, researchers say", Interview, Baltimore Sun, Dennis O'Brien, author.
· "Mister Clone", Interview, L'espresso (Italy), Daniela Cipolloni, author.
· "Anti-Ban Billionaires", Interview, Forbes Magazine, Matthew Herper and Robert Langreth, authors.
· "323 years of stem cell research, 37 years of politics", Harvard Stem Cell Institute Summer Seminar Series, Harvard University, Cambridge, Massachusetts.
· "Stem Cell Research Debate", Radio Call-In Interview, Radio Islam (WCEV - Chicago), Carlie Pierson, Producer.
· "Veto de George W. Bush: Une grande déception, mais pas une surprise", Interview, Le Figaro (France), Philippe Berry, author.
· "The Stem Cell Future", Live News Interview, New England Cable News (NECN), Jonah Davis, producer.
· "Ask the Expert", Magazine Interview, Soap Opera Digest, Naomi Rabinowitz, author.
· "Philosophy and Ethics in Human Embryo Research", (with Thorsten Schlaeger) Harvard Stem Cell Institute Summer Seminar Series, Harvard University, Cambridge, Massachusetts.
· "Stem Cell Package", Film Interview, Emerson College, Carrie Sheffield, author.
· "Scientists Identify Genes That Let Stem Cells Stay Stem Cells", Interview, Bloomberg, Rob Waters, author.
· "Comments on Science and Policy in Stem Cell Research", Testimony, Congressional Simulation for students, Kennedy School of Government, Harvard University.
· "Compensation for Oocytes: Personal Liberty v. Paternalism", Lecture and Discussion, Brown Bag Bioethics Discussion, Division of Hematology/Oncology, Children's Hospital Boston and Harvard Stem Cell Institute.
· “Introduction to the Science of Stem Cells”, Guest Faculty, Suffolk University Law School, Annual Intellectual Property Law Conference, Boston, Massachusetts.
· "Nuclear Transfer: From Zoology to Medicine", Lecture, Knight Science Journalism Fellowships/Nieman Foundation Fellowships, Harvard Stem Cell Institute, Harvard University, and Massachusetts Institute of Technology.
· "Stem Cells in the Blood", Essay, International Society for Stem Cell Research, public education website.
· "Stem Cell Ethics 101", Lecture, Knight Science Journalism Fellowships/Nieman Foundation Fellowships, Harvard Stem Cell Institute, Harvard University, and Massachusetts Institute of Technology.
· “Conditional Transgene Expression in Human Embryonic Stem Cells”, Duke University Medical Center, Durham, North Carolina.
· “What Happens Next with Stem Cells? The Hope, the Hype, and the Politics”, Panel Discussion, The BioAgenda Institute, Boston Issues Roundtable. David Ewing Duncan, host and moderator.
· 2006"Whose life? Stem-cell research poses tough issues for Ohio lawmakers", Newspaper Interview, The Columbus Dispatch (Ohio), Jim Siegel, author.

2005
· “Embryonic stem cell research: how, when, and why?”, Lecture, The Cambridge Saloon Salon at Redline, Center for Naturalism. Cambridge, Massachusetts.
· "New Research: Americans Torn over Doing Right Thing", Newspaper Interview, The Patriot Ledger, Quincy, Massachusetts, Sarah Baldauf, author.
· "New Stem Cell Tactics Preserve Embryos", Newspaper Interview, Harvard Crimson, Risheng Xu, author.
· "Embryonic stem cell research: A political and scientific timeline", Lecture, Intellectual Property Office, Children's Hospital Boston, Boston, Massachusetts.
· "Research Using Human ES Cells: A Tale of Two Cities…", Lecture and Panel, Emerging Technologies Conference, Massachusetts Institute of Technology, "Stem Cells and the State" Charles C. Mann, Moderator. Cambridge, Massachusetts.
· "Personalized Medicine: Stem Cells and Genetics", Invited Panelist, Stanford University, Department of Genetics Annual Retreat, Julie Baker, Ph.D., Moderator. Monterey, California.
· "Embryonic Stem Cells: Working Towards a More Complete Understanding of Human Developmental Genetics and Congenital Diseases", Stanford University, Department of Genetics Annual Retreat.
· "Braving Medicine's Frontier", Magazine Interview, MIT Technology Review, September 2005, Charles C. Mann, author.
· "Making Sense of Stem Cells", Film Interview, International Society for Stem Cell Research, Susan J. Garfinkel, Ph.D., Public Education Committee Chair, organizer. (go to site online)
· "Embryonic Stem Cell Research: a Political and Scientific Time-Line" Harvard Stem Cell Institute Summer Seminar Series, Harvard University, Cambridge, Massachusetts.
· "Stem Cell Funds Launch a Scientific Gold Rush", Newspaper Interview, Contra Costa Times (Walnut Creek, CA), Betsy Mason, author.
· “Conducting Stem Cell Research”, Newspaper Interview, Taunton Gazette (Taunton, MA), Joanna James, author.
· "Stem Cell Research: Past, Present, and Future", Morton Hospital and Medical Center Graduate Medical Education Seminar, Taunton, Massachusetts.
· "The State of Stem Cells", Live Radio Panel, on The Exchange, New Hampshire Public Radio, Two person panel with Eric Cohen, Director of the Biotechnology & American Democracy Program at the Ethics and Public Policy Center, Editor of The New Atlantis and Consultant to the President’s Council on Bioethics, Laura Knoy, host. (go to site online)
· Town Hall Meeting on Stem Cell Research, Lecture and Panel, Jamaica Plain, Massachusetts. State Representative Jeffrey Sanchez, moderator.
· "The Cloning Process", Photo Essay, NOVA Science NOW, Accompanying material for segment on Stem Cells. (go to site online)
· “Clear Science, Uncertain Future?”, Essay, Bridges Magazine, Office of Science and Technology, Embassy of Austria, Washington, D.C., (go to site online)
· “Inside a Stem Cell Laboratory”, Lecture and Panel, Stanford University Club of New England and Gadsby Hannah's Technology and Emerging Growth Group (Gadsby Hannah LLP), Boston, MA.
· New England Cable News Network (NECN), Television Interview, regarding science and policy issues in embryonic stem cell research.
· MassCURE, News Conference, Commonwealth of Massachusetts State House.
· "Stem Cell Research: Policy and Personal Perspectives", Lecture, Frontiers of Health Science on Friday, Museum of Science, Boston, Massachusetts.
· “The Global State of Stem Cells & Cloning in Science, Ethics & Law”, Lecture, Panel, Newspaper Interviews, Television Interview, Pontifical University Regina Apostolorum, Rome, Italy. Eric Cohen, Senior Research Consultant, President’s Council on Bioethics, Moderator.
· “Being a Young Investigator in a Contentious Field” News Conference “The Politics and Promise of Stem Cell Research”, Howard Hughes Medical Institute (HHMI) in collaboration with the Center for Strategic and International Studies (CSIS), Washington, D.C., Leonard Zon, organizer.
· “Stem Cell Research: A View from the Front Lines.” Lecture and Panel, National Association of Science Writers at the AAAS Annual Meeting, , George Washington University, Washington, D.C.
· “Stem Cell Research at Harvard.” Lecture and Panel, Boston Chapter of Hadassah and Mishkan Tefilah Synagogue.
· “A New Twist for Embryonic Stem Cells in the Heart”. Lay Review, International Society for Stem Cell Research (ISSCR) website.
· “Human Embryonic Stem Cells: Genetic Modification and Directed Differentiation”, Churchill College, Møller Centre, University of Cambridge, England.
· “A Personal View of Stem Cell Research”, Lecture and Panel, Boston Athenaeum, Ann Parson, moderator.

2004
· “Stem Cell Research Deserves Respect, Not Scorn”, Essay, Salt Lake Tribune, Utah Voices, Salt Lake City, Utah.
· “When Stem Cell Research Gets Personal”, Newsmagazine Interview, Boston Globe Sunday Magazine, Ann Parson, writer.
· "Human Embryonic Stem Cell Research: One Perspective" Lecture and Discussion, Brown Bag Bioethics Discussion, Division of Hematology/Oncology, Children's Hospital Boston.
· “The Controversies in Stem Cell Research”, Live Radio Interview, Market Wrap, WBIX Radio Boston, Mark Mills, host.
· "Stem Cell Research: The Struggle Between Politics & Medicine", Lecture and Discussion, Jewish Alliance for Law and Social Action, Young Social Activist Dinner and Lecture, with Cynthia Stone Creem, State Senator for Massachusetts, Temple Ohabei Shalom, Brookline, MA.
· Research Advocacy, Joint Steering Committee for Public Policy (ASCB), Capitol Hill Day, Washington, D.C.
· “Using Embryonic Stem Cells to Understand Human Development and Disease”, Department of Biology, Utah State University, Logan, Utah.
· “Biological Engineering Opportunities at MIT”, Biotechnology Center, Utah State University, Logan, Utah.
· “Stem Cell Research: Origins, State of the Art, and Future Directions”, Lecture, MIT Senior Congressional Staff Seminar: “Social and Policy Implications of Advancing Health Science and Technology”, Stephen Ansolabehere, Ph.D. and Robert Weinberg, Ph.D., organizers. Jonathan Gruber, Ph.D., moderator.
· “Stem Cell Debate Reignited”, Radio Interview, WBUR Radio Boston, Rachel Gotbaum, author.

2003
· “Stem Cell Research: Science and Politics”, Lecture and Panel, Whitehead Institute Board of Associates Annual Meeting, Harvey Lodish, Ph.D., moderator.
·  “With Respect and Conscience”, Magazine Interview, Paradigm magazine, Whitehead Institute for Biomedical Research, Melissa Withers, author. (go to site online)
· “Stem Cell Research”, Testimony, State of Utah Legislature, Democrat Representatives’ Caucus.
· “Stem Cell Research”, Testimony, Commonwealth of Massachusetts State House, joint legislative session on stem cell research.

2002
· “Genetic Engineering of Human and Murine Embryonic Stem Cells”, Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge, Massachusetts.
· “Hematopoiesis and Human Embryonic Stem Cells”, Mammalian Development Seminars, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
· “Clonal Selection: The Leukemic Process in Fanconi Anemia”, Thesis Defense, Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon.

2001 and earlier
· 2001 “Clonal Evolution in Fanconi Anemia”, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.
· 2001 “Genetic Determinants in Secondary MDS/AML and Fanconi Anemia”, Terry Fox Cancer Research Laboratories, Vancouver, B.C.
· 2000 “Genes Involved in Copper Metabolism”, Grand Rounds, Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon.
· 1999 “Genetic Analysis of Secondary Myelodysplastic Syndrome”, Departmental Seminar, Molecular and Medical Genetics, Oregon Health Sciences University, Portland, Oregon.
· 1997 “Spongiform Encephalopathies, Prions, and Genetics”, Department of Molecular and Medical Genetics Student Seminar, Oregon Health Sciences University, Portland, Oregon.
· 1994 “The Genetics of Neurofibromatosis”, Neuroscience Graduate Program Student Seminar, University of Pennsylvania, Philadelphia, Pennsylvania.
· 1992 “Gene Mapping in Neuromuscular Disease”, Eccles Institute Public Outreach, Department of Pediatrics, Division of Clinical Genetics, University of Utah, Salt Lake City, Utah.